TMates vs CoreAgeRx: Pricing, meds, access compared

TMates vs CoreAgeRx answers whether you want a flat, physician-forward semaglutide program or a lower-cost option that lists both semaglutide and tirzepatide at fixed monthly rates. Quick verdict: TMates emphasizes 24/7 U.S. doctor access and a $199/month flat semaglutide price; CoreAgeRx emphasizes lower monthly rates for semaglutide and tirzepatide and a promise of the same price every month.

Explore TMates $199/month semaglutide

Key differences at a glance for TMates vs CoreAgeRx

Compare the most distinctive differences below: monthly price model, medication options and dosing, clinician access and visit format, state coverage and sourcing, and regulatory notes about compounded medications. Each section contrasts the two providers using only the supplied facts.

1. Monthly price model

TMates: Priced at a flat $199/month, the same rate at every dose, with no step-up fees as dosage escalates. The landing copy and FAQ state TMates is priced at $199/month flat, the same rate at every dose, enabling predictable budgeting for the program.

CoreAgeRx: Advertises lower listed monthly prices for each medication and stresses “Same Price. Every Month.” CoreAgeRx lists semaglutide at $79/month and tirzepatide at $129/month and promotes no price hikes, no membership fee, and no billing surprises. CoreAgeRx warns readers that pricing, eligibility, pharmacy, state coverage and renewal terms may change, and recommends confirming details before enrollment.

2. Medication offerings and dosing

TMates: Focused on clinically dosed compounded semaglutide formulated in U.S. facilities. TMates notes compounded semaglutide is not an FDA approved finished product and contrasts it with branded agents by saying compounded semaglutide gives more flexibility in dosage and access at lower price points.

CoreAgeRx: Lists both tirzepatide and semaglutide on the captured landing page. The page shows tirzepatide available up to 7.5 mg at $129/month and semaglutide up to 1.0 mg at $79/month. CoreAgeRx also includes the statement that treatment is available only when a licensed clinician determines it is medically appropriate and that medication specific approval status must be confirmed.

See CoreAgeRx semaglutide and tirzepatide prices

3. Clinician access and visit format

TMates: Advertises 24/7 access to U.S.-based doctors across all 50 states and includes virtual check-in appointments for ongoing medical oversight. TMates positions this as actual physician availability, not just messaging support.

CoreAgeRx: Captured landing content highlights a 3-minute online visit and clinician review for treatment eligibility. CoreAgeRx emphasizes quick visits and clinician-reviewed treatment but captured details about ongoing physician availability or 24/7 access were not published in the captured evidence.

4. State coverage, sourcing, and shipping

TMates: States licensed coverage in all 50 states and notes medications are formulated in U.S.-based facilities. TMates also states it ships to most states and that availability is based on medical eligibility. The provider also states it does not bill insurance in the captured FAQ and operates direct pay for compounded GLP-1 telehealth.

CoreAgeRx: The captured landing page does not verify full state coverage details. CoreAgeRx advises users to confirm eligibility, medication, total cost, renewal terms and state availability before enrollment. The landing copy includes the general note that treatment is available only when a licensed clinician determines it is medically appropriate.

5. Regulatory and compound medication notes

Both providers include regulatory qualifiers about compounded medications. TMates explicitly states compounded medications are not FDA approved and not reviewed by FDA for safety, effectiveness or quality. CoreAgeRx captured content also notes that medication specific approval status must be confirmed and that branded and compounded products are not interchangeable.

Comparison table: TMates vs CoreAgeRx

Criteria	TMates	CoreAgeRx
Starting monthly price (captured)	$199/month flat for semaglutide	$79/mo semaglutide; $129/mo tirzepatide
Price model	Same price at every dose, no step-up fees	Same price every month; no membership fee, but verify terms
Medications listed	Clinically dosed compounded semaglutide; no branded Ozempic or Wegovy listed	Semaglutide and tirzepatide listed on landing page
Clinician access	24/7 U.S. doctor access and virtual check-ins	3-minute online visit; clinician-reviewed eligibility
State coverage and sourcing	Licensed coverage in all 50 states; meds formulated in U.S. facilities; ships to most states	State coverage and pharmacy details not fully verified; confirm before enrolling
Regulatory note	Compounded meds not FDA approved or reviewed	Medication specific approval status must be confirmed; compounded and branded not interchangeable

Start TMates enrollment and check eligibility

Which to choose

Choose TMates if you prioritize 24/7 access to U.S. doctors, a U.S. sourcing claim, and a predictable flat $199/month semaglutide program with no step-up fees as dosage escalates. Choose CoreAgeRx if lower listed monthly pricing for semaglutide or tirzepatide and a promise of the same price every month matter more, but be sure to confirm eligibility, pharmacy, state coverage and renewal terms before enrolling.

Compare TMates details and FAQ